313 related articles for article (PubMed ID: 29485952)
21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the Impact of Sample Medication on Subsequent Patient Adherence.
Pringle JL; Aldridge A; Kearney SM; Grasso K; Radack J; Hogue S; Manolis C
J Manag Care Spec Pharm; 2016 Nov; 22(11):1262-1269. PubMed ID: 27783544
[TBL] [Abstract][Full Text] [Related]
23. Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed.
Kennedy J; Tuleu I; Mackay K
J Manag Care Pharm; 2008; 14(6):553-60. PubMed ID: 18693779
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV.
Dunn K; Lafeuille MH; Jiao X; Romdhani H; Emond B; Woodruff K; Pesa J; Tandon N; Lefebvre P
J Manag Care Spec Pharm; 2018 Oct; 24(10):1040-1051. PubMed ID: 29877140
[TBL] [Abstract][Full Text] [Related]
25. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
Jing S; Naliboff A; Kaufman MB; Choy M
J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
[TBL] [Abstract][Full Text] [Related]
26. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
[TBL] [Abstract][Full Text] [Related]
27. Prescription drug coverage satisfaction, cost-reducing behavior, and medication nonadherence among Medicare beneficiaries with type 2 diabetes.
He Q; Silverman CL; Park C; Tiu GF; Ng BP
J Manag Care Spec Pharm; 2021 Jun; 27(6):696-705. PubMed ID: 34057396
[No Abstract] [Full Text] [Related]
28. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
Perera PN; Guy MC; Sweaney AM; Boesen KP
J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
[TBL] [Abstract][Full Text] [Related]
29. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M
J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
[TBL] [Abstract][Full Text] [Related]
30. Association of Medication Adherence with Hospital Utilization and Costs Among Elderly with Diabetes Enrolled in a State Pharmaceutical Assistance Program.
Pednekar P; Heller DA; Peterson AM
J Manag Care Spec Pharm; 2020 Sep; 26(9):1099-1108. PubMed ID: 32857648
[TBL] [Abstract][Full Text] [Related]
31. How Much Does Medication Nonadherence Cost the Medicare Fee-for-Service Program?
Lloyd JT; Maresh S; Powers CA; Shrank WH; Alley DE
Med Care; 2019 Mar; 57(3):218-224. PubMed ID: 30676355
[TBL] [Abstract][Full Text] [Related]
32. Effects of Medication Nonadherence and Comorbidity on Health Resource Utilization in Schizophrenia.
Desai R; Nayak R
J Manag Care Spec Pharm; 2019 Jan; 25(1):37-46. PubMed ID: 30589635
[TBL] [Abstract][Full Text] [Related]
33. Integrating E-Prescribing and Pharmacy Claims Data for Predictive Modeling: Comparing Costs and Utilization of Health Plan Members Who Fill Their Initial Medications with Those Who Do Not.
Chang HY; Kan HJ; Shermock KM; Alexander GC; Weiner JP; Kharrazi H
J Manag Care Spec Pharm; 2020 Oct; 26(10):1282-1290. PubMed ID: 32996394
[TBL] [Abstract][Full Text] [Related]
34. Impact of Environmental Factors on Differences in Quality of Medication Use: An Insight for the Medicare Star Rating System.
Desai V; Nau D; Conklin M; Heaton PC
J Manag Care Spec Pharm; 2016 Jul; 22(7):779-86. PubMed ID: 27348278
[TBL] [Abstract][Full Text] [Related]
35. Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims.
Vyas A; Descoteaux A; Kogut S; Parikh MA; Campbell PJ; Green A; Westrich K
J Manag Care Spec Pharm; 2022 Aug; 28(8):831-844. PubMed ID: 35876294
[No Abstract] [Full Text] [Related]
36. Impact of medication synchronization programs on proportion of days covered (PDC) scores and Medicare Part D medication-related adherence metrics.
Bernard K; Cowles B; McCall K; Henningsen RM; O'Toole M; Tu C
J Am Pharm Assoc (2003); 2019; 59(3):343-348. PubMed ID: 30940515
[TBL] [Abstract][Full Text] [Related]
37. Association Between Opioid Tapering and Subsequent Health Care Use, Medication Adherence, and Chronic Condition Control.
Magnan EM; Tancredi DJ; Xing G; Agnoli A; Jerant A; Fenton JJ
JAMA Netw Open; 2023 Feb; 6(2):e2255101. PubMed ID: 36749586
[TBL] [Abstract][Full Text] [Related]
38. Understanding reasons for nonadherence to medications in a medicare part d beneficiary sample.
Hincapie AL; Taylor AM; Boesen KP; Warholak T
J Manag Care Spec Pharm; 2015 May; 21(5):391-9. PubMed ID: 25943000
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Eligibility Criteria Used to Identify Patients for Medication Therapy Management Services: A Retrospective Cohort Study in a Medicare Advantage Part D Population.
Lee JS; Yang J; Stockl KM; Lew H; Solow BK
J Manag Care Spec Pharm; 2016 Jan; 22(1):22-30. PubMed ID: 27015048
[TBL] [Abstract][Full Text] [Related]
40. Erectile Dysfunction Medication Use in Veterans Eligible for Medicare Part D.
Spencer SH; Suda KJ; Smith BM; Huo Z; Bailey L; Stroupe KT
J Manag Care Spec Pharm; 2016 Jul; 22(7):818-24. PubMed ID: 27348283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]